NASDAQ:ROKA

(ROKA) (ROKA) Stock Price, News & Analysis

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
$0.65
$0.69
50-Day Range
N/A
52-Week Range
$0.60
$6.20
Volume
242,292 shs
Average Volume
371,374 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
ROKA stock logo

About (ROKA) Stock (NASDAQ:ROKA)

Sorrento Tech, Inc., formerly Roka Bioscience, Inc., is a molecular diagnostics company. The Company is focused on the development and commercialization of molecular assay technologies for the detection of foodborne pathogens under the Atlas brand name. The Company offers Atlas Detection Assays and Atlas instrument in the North American food safety testing market and has rights to develop and commercialize its molecular testing solutions for a range of other industrial applications. The detection of foodborne pathogens is accomplished using culture-based assays, immunochemical-based assays and molecular-based assays. The Company sells its Atlas Detection Assays and related consumable supplies for use with its Atlas instruments. The Company's Atlas instrument is an automated molecular diagnostic testing and a sample-in-result-out instrument that eliminates the need for batch processing and automates all aspects of molecular diagnostic testing on a single, integrated platform.

ROKA Stock News Headlines

The Best AI Stock to Own in the World Today is Trading for Just $25
“Titan of Tech” Bets Big on Tiny AI Company He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal… But our research shows his latest investment could be his most successful venture yet.
IRONMAN 70.3 Lapu-Lapu set to fire off
The Best AI Stock to Own in the World Today is Trading for Just $25
“Titan of Tech” Bets Big on Tiny AI Company He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal… But our research shows his latest investment could be his most successful venture yet.
See More Headlines
Receive ROKA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for (ROKA) and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
5/11/2017
Today
4/24/2024

Industry, Sector and Symbol

Sector
N/A
Industry
N/A
Sub-Industry
N/A
Current Symbol
NASDAQ:ROKA
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
These 7 Stocks Will Be Magnificent in 2024 Cover

With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.

Get This Free Report

Key Executives

  • Paul G. Thomas (Age 61)
    Chairman of the Board
  • Mary Duseau (Age 52)
    President, Chief Executive Officer, Secretary, Director
  • Lars Boesgaard (Age 47)
    Chief Financial Officer, Vice President, Treasurer
  • Nicholas J. Valeriani (Age 60)
    Director
  • Michael P. Doyle Ph.D. (Age 67)
    Independent Director
  • David W. J. McGirr (Age 62)
    Independent Director

ROKA Stock Analysis - Frequently Asked Questions

How were (ROKA)'s earnings last quarter?

(ROKA) (NASDAQ:ROKA) posted its quarterly earnings results on Thursday, May, 11th. The medical research company reported ($1.53) earnings per share for the quarter, missing analysts' consensus estimates of ($1.19) by $0.34. The medical research company had revenue of $2.04 million for the quarter.

What other stocks do shareholders of (ROKA) own?
This page (NASDAQ:ROKA) was last updated on 4/24/2024 by MarketBeat.com Staff

From Our Partners